112 related articles for article (PubMed ID: 18566582)
1. Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia.
Horacek JM; Tichy M; Jebavy L; Pudil R; Ulrychova M; Maly J
Exp Oncol; 2008 Jun; 30(2):157-9. PubMed ID: 18566582
[TBL] [Abstract][Full Text] [Related]
2. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
[TBL] [Abstract][Full Text] [Related]
3. The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia.
Horacek JM; Vasatova M; Tichy M; Pudil R; Jebavy L; Maly J
Exp Oncol; 2010 Jul; 32(2):97-9. PubMed ID: 20693970
[TBL] [Abstract][Full Text] [Related]
4. Multimarker approach to evaluation of cardiac toxicity during preparative regimen and hematopoietic cell transplantation.
Horacek JM; Tichy M; Pudil R; Jebavy L; Zak P; Ulrychova M; Slovacek L; Maly J
Neoplasma; 2008; 55(6):532-7. PubMed ID: 18999883
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
Horacek JM; Pudil R; Tichy M; Jebavy L; Zak P; Slovacek L; Maly J
Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253
[TBL] [Abstract][Full Text] [Related]
7. Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia.
Horacek JM; Jebavy L; Vasatova M; Pudil R; Tichy M; Jakl M; Maly J
Bratisl Lek Listy; 2013; 114(12):708-10. PubMed ID: 24329509
[TBL] [Abstract][Full Text] [Related]
8. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
[TBL] [Abstract][Full Text] [Related]
9. Assessment of anthracycline-induced cardiotoxicity with electrocardiography.
Horacek JM; Jakl M; Horackova J; Pudil R; Jebavy L; Maly J
Exp Oncol; 2009 Jun; 31(2):115-7. PubMed ID: 19550402
[TBL] [Abstract][Full Text] [Related]
10. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
[TBL] [Abstract][Full Text] [Related]
11. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria.
Collinson PO; Gaze DC; Morris F; Morris B; Price A; Goodacre S
Ann Clin Biochem; 2006 Jul; 43(Pt 4):273-80. PubMed ID: 16824277
[TBL] [Abstract][Full Text] [Related]
12. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T.
McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
Eur Heart J; 2008 Dec; 29(23):2843-50. PubMed ID: 18682444
[TBL] [Abstract][Full Text] [Related]
13. The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature.
Mavinkurve-Groothuis AM; Kapusta L; Nir A; Groot-Loonen J
Pediatr Hematol Oncol; 2008 Sep; 25(7):655-64. PubMed ID: 18850478
[TBL] [Abstract][Full Text] [Related]
14. Temporal pattern of cardiac troponin I after thoracotomy and lung surgery.
Vikenes K; Andersen KS; Farstad M; Nordrehaug JE
Int J Cardiol; 2004 Sep; 96(3):403-7. PubMed ID: 15301894
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a proposed panel of cardiac markers for the diagnosis of acute myocardial infarction in patients with atraumatic chest pain.
Chang CC; Ip MP; Hsu RM; Vrobel T
Arch Pathol Lab Med; 1998 Apr; 122(4):320-4. PubMed ID: 9648898
[TBL] [Abstract][Full Text] [Related]
16. Detection of minor myocardial injury after successful percutaneous transluminal coronary angioplasty with or without stenting.
Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
Med Sci Monit; 2000; 6(4):708-12. PubMed ID: 11208396
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of cardiac troponin I and other marker proteins in patients with chronic renal failure.
Nakai K; Nakai K; Nagane Y; Obara W; Sato M; Ohi K; Matsumoto N; Takanashi N; Itoh C
Clin Exp Nephrol; 2004 Mar; 8(1):43-7. PubMed ID: 15067515
[TBL] [Abstract][Full Text] [Related]
18. Progress in myocardial damage detection: new biochemical markers for clinicians.
Mair J
Crit Rev Clin Lab Sci; 1997; 34(1):1-66. PubMed ID: 9055056
[TBL] [Abstract][Full Text] [Related]
19. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
[TBL] [Abstract][Full Text] [Related]
20. [Multi-marker approach in the diagnostics of cardiac diseases by protein biochip technology].
Vasatová M; Tichý M; Horácek JM; Pudil R; Horáková L; Palicka V
Cas Lek Cesk; 2009; 148(12):591-6. PubMed ID: 20662394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
